Annual report pursuant to Section 13 and 15(d)

INCOME TAXES

v3.24.0.1
INCOME TAXES
12 Months Ended
Dec. 31, 2023
INCOME TAXES  
INCOME TAXES

NOTE M - INCOME TAXES

Income tax (benefit) expense consists of (in thousands):

    

Current

    

Deferred

    

Total

Year Ended December 31, 2023:

U.S. federal

$

(1,570)

$

(806)

$

(2,376)

U.S. state

 

128

 

(110)

 

18

Foreign

 

242

 

-

 

242

Total income tax (benefit) expense

$

(1,200)

$

(916)

$

(2,116)

    

Current

    

Deferred

    

Total

Year Ended December 31, 2022:

U.S. federal

$

10,537

$

(862)

$

9,675

U.S. state

 

3,015

 

(405)

 

2,610

Foreign

 

2,856

 

(1,120)

 

1,736

Total income tax expense (benefit)

$

16,408

$

(2,387)

$

14,021

    

Current

    

Deferred

    

Total

Year Ended December 31, 2021:

U.S. federal

$

11,003

$

(1,899)

$

9,104

U.S. state

 

1,780

 

(402)

 

1,378

Foreign

 

2,068

 

(891)

 

1,177

Total income tax expense (benefit)

$

14,851

$

(3,192)

$

11,659

Tax Rate Reconciliation

The provision for income taxes on pre-tax income differs from the amount computed by applying the U.S. federal statutory income tax rate of 21.0% for the years ended December 31, 2023, 2022 and 2021 due to the following (in thousands):

    

2023

    

2022

    

2021

Provision for income tax at the federal statutory rate

$

(1,613)

$

12,155

$

10,033

State taxes

 

165

 

1,959

 

1,357

Permanent differences

 

(328)

 

218

 

755

Change in valuation allowance 

 

(1,313)

 

17

 

1,012

Executive compensation

3,016

2,562

1,934

Return to provision

151

591

659

FDII deduction

-

(3,014)

(4,093)

R&D credit

(1,174)

-

-

Stock-based compensation

(1,020)

-

-

Other

 

-

 

(467)

 

2

Total income tax (benefit) expense

$

(2,116)

$

14,021

$

11,659

Significant Components of Deferred Taxes

Deferred tax assets and liabilities reflect the net effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The tax effects of temporary differences that give rise to deferred tax assets and deferred tax liabilities as of December 31, 2023 and 2022 are as follows (in thousands):

    

2023

    

2022

Deferred tax assets:

 

  

Net operating losses

$

2,005

$

94

Foreign tax credit carryforwards

 

1,109

 

67

Inventory basis differences

 

9,269

 

10,511

Maintenance deposit payments

 

-

 

154

Deferred revenue

 

726

 

328

Allowance for doubtful accounts

 

237

 

285

Start up costs

634

688

Stock-based compensation

966

1,408

Outside basis difference

-

1,313

Accrued expenses

 

22

 

908

Section 174 capitalization

2,971

1,722

Lease obligations

7,010

7,922

R&D credit

434

-

Other

 

445

 

190

Total deferred tax assets

25,828

 

25,590

Deferred tax liabilities:

 

 

Fixed assets

 

(6,489)

 

(5,167)

Right-of-use assets

(6,659)

(7,659)

Intangible assets

(477)

(164)

Total deferred tax liabilities

 

(13,625)

 

(12,990)

Valuation Allowances

-

(1,313)

Deferred income taxes, net

$

12,203

$

11,287

The deferred tax assets are adjusted by a valuation allowance if, based on the weight of available evidence, it is more likely than not that a portion or all the deferred assets will not be realized. The Company has evaluated the positive and negative evidence bearing upon its ability to realize the deferred tax assets. After considering all of the evidence, both positive and negative, it was determined that it is more likely than not, that the benefit from an outside basis difference of an investment acquired in 2022 will not be realized. Accordingly, the Company has recorded a valuation allowance of $1.3 million on the deferred tax assets related to the outside basis difference as of December 31, 2023.

At December 31, 2023 and December 31, 2022, the Company had net operating losses available for carry-forward for Federal income tax purposes of approximately $7.8 million and $0.4 million, respectively. These net operating loss carryforwards acquired prior to 2023 will expire on various dates through 2034. Utilization of the net operating loss carryforwards as of December 31, 2023 are subject to annual limitation under Sec. 382 of the Internal Revenue Code. A deferred tax asset has been recorded only for those carryforwards that the Company expects to utilize prior to expiration.

The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction, various state jurisdictions, and in Ireland. Tax years beginning in 2019 through 2022 are open for examination by the U.S. Internal Revenue Service and tax years beginning in 2018 through 2022 are open for examination by various state taxing jurisdictions in which the Company is subject to tax. Tax years beginning in 2018 through 2022 are open for examination by the Irish taxing authorities.

ASC 740, Income Taxes, provides that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. ASC 740 also provides guidance on measurement, derecognition,

classification, interest and penalties, accounting in interim periods, and disclosure and transition. As of December 31, 2023 and 2022, there was no reserve for uncertain tax positions.